Monday, May 28, 2007

Replidyne (Daiichi Suntory / Asubio)











Faropenem® is the first oral penem antibiotic to reach an advanced stage of clinical development in the U.S. and is under development for community-acquired respiratory infections. Community antibiotics are generally used to treat infections acquired outside the hospital. Currently in Phase III trials.

No comments: